Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?-Reply.
Publication
, Journal Article
Mann, DL; Hernandez, AF; Braunwald, E
Published in: JAMA Cardiol
June 1, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
June 1, 2022
Volume
7
Issue
6
Start / End Page
657 / 658
Location
United States
Related Subject Headings
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Mann, D. L., Hernandez, A. F., & Braunwald, E. (2022). Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?-Reply. JAMA Cardiol, 7(6), 657–658. https://doi.org/10.1001/jamacardio.2022.0787
Mann, Douglas L., Adrian F. Hernandez, and Eugene Braunwald. “Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?-Reply.” JAMA Cardiol 7, no. 6 (June 1, 2022): 657–58. https://doi.org/10.1001/jamacardio.2022.0787.
Mann DL, Hernandez AF, Braunwald E. Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?-Reply. JAMA Cardiol. 2022 Jun 1;7(6):657–8.
Mann, Douglas L., et al. “Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?-Reply.” JAMA Cardiol, vol. 7, no. 6, June 2022, pp. 657–58. Pubmed, doi:10.1001/jamacardio.2022.0787.
Mann DL, Hernandez AF, Braunwald E. Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?-Reply. JAMA Cardiol. 2022 Jun 1;7(6):657–658.
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
June 1, 2022
Volume
7
Issue
6
Start / End Page
657 / 658
Location
United States
Related Subject Headings
- 3201 Cardiovascular medicine and haematology